Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Pregnancy and Childbirth
Published in: BMC Pregnancy and Childbirth 1/2015

Open Access 01-12-2015 | Research article

Maternal psychiatric disease and epigenetic evidence suggest a common biology for poor fetal growth

Authors: Timothy H. Ciesielski, Carmen J. Marsit, Scott M. Williams

Published in: BMC Pregnancy and Childbirth | Issue 1/2015

Login to get access

Abstract

Background

We sought to identify and characterize predictors of poor fetal growth among variables extracted from perinatal medical records to gain insight into potential etiologic mechanisms. In this process we reevaluated a previously observed association between poor fetal growth and maternal psychiatric disease.

Methods

We evaluated 449 deliveries of >36 weeks gestation that occurred between 9/2008 and 9/2010 at the Women and Infants Hospital in Providence Rhode Island. This study group was oversampled for Small-for-Gestational-Age (SGA) infants and excluded Large-for-Gestational-Age (LGA) infants. We assessed the associations between recorded clinical variables and impaired fetal growth: SGA or Intrauterine Growth Restriction (IUGR) diagnosis. After validating the previously observed association between maternal psychiatric disease and impaired fetal growth we addressed weaknesses in the prior studies by explicitly considering antidepressant use and the timing of symptoms with respect to pregnancy. We then evaluated DNA methylation levels at 27 candidate loci in placenta from a subset of these deliveries (n = 197) to examine if epigenetic variation could provide insight into the mechanisms that cause this co-morbidity.

Results

Infants of mothers with prenatal psychiatric disease (Depression, Anxiety, OCD/Panic) had increased odds of poor fetal growth (ORadjusted = 3.36, 95%CI: 1.38-8.14). This relationship was similar among those who were treated with antidepressants (ORadjusted = 3.69, 95%CI: 1.31-10.45) and among those who were not (ORadjusted = 3.19, 95%CI: 1.30-7.83). Among those with a history of psychiatric disease but no active disease in pregnancy the ORadjusted was 0.45 (95%CI: 0.09-2.35). A locus near the transcription start site of the leptin receptor (cg21655790) had methylation levels that were decreased in the presence of: 1) SGA/IUGR, and 2) active but not resolved psychiatric disease (among mothers not on antidepressants).

Conclusions

These results validate and further characterize the association between maternal psychiatric disease and poor fetal growth. Because the association appears to depend on active psychiatric disease, this suggests a transient and potentially modifiable pathophysiology. The molecular findings in this study suggest that altered leptin signaling may be involved in the biological mechanisms that link prenatal maternal psychiatric symptoms and poor fetal growth.
Appendix
Available only for authorised users
Literature
1.
Szegda K, Markenson G, Bertone-Johnson ER, Chasan-Taber L. Depression during pregnancy: a risk factor for adverse neonatal outcomes? A critical review of the literature. J Matern Fetal Neonatal Med. 2014;27(9):960–7.PubMedCrossRef
2.
Grigoriadis S, VonderPorten EH, Mamisashvili L, Tomlinson G, Dennis CL, Koren G, et al. The impact of maternal depression during pregnancy on perinatal outcomes: a systematic review and meta-analysis. J Clin Psychiatry. 2013;74(4):e321–41.PubMedCrossRef
3.
Grote NK, Bridge JA, Gavin AR, Melville JL, Iyengar S, Katon WJ. A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. Arch Gen Psychiatry. 2010;67(10):1012–24.PubMedPubMedCentralCrossRef
4.
Lee HC, Lin HC. Maternal bipolar disorder increased low birthweight and preterm births: a nationwide population-based study. J Affect Disord. 2010;121(1–2):100–5.PubMedCrossRef
5.
Jablensky AV, Morgan V, Zubrick SR, Bower C, Yellachich LA. Pregnancy, delivery, and neonatal complications in a population cohort of women with schizophrenia and major affective disorders. Am J Psychiatry. 2005;162(1):79–91.PubMedCrossRef
6.
Warren SL, Racu C, Gregg V, Simmens SJ. Maternal panic disorder: Infant prematurity and low birth weight. J Anxiety Disord. 2006;20(3):342–52.PubMedCrossRef
7.
Banhidy F, Acs N, Puho E, Czeizel AE. Association between maternal panic disorders and pregnancy complications and delivery outcomes. Eur J Obstet Gynecol Reprod Biol. 2006;124(1):47–52.PubMedCrossRef
8.
Hironaka M, Kotani T, Sumigama S, Tsuda H, Mano Y, Hayakawa H, et al. Maternal mental disorders and pregnancy outcomes: a clinical study in a Japanese population. J Obstet Gynaecol Res. 2011;37(10):1283–9.PubMedCrossRef
9.
Wadhwa PD, Sandman CA, Porto M, Dunkel-Schetter C, Garite TJ. The association between prenatal stress and infant birth weight and gestational age at birth: a prospective investigation. Am J Obstet Gynecol. 1993;169(4):858–65.PubMedCrossRef
10.
Dejin-Karlsson E, Hanson BS, Ostergren PO, Lindgren A, Sjoberg NO, Marsal K. Association of a lack of psychosocial resources and the risk of giving birth to small for gestational age infants: a stress hypothesis. BJOG. 2000;107(1):89–100.PubMedCrossRef
11.
Rondo PH, Ferreira RF, Nogueira F, Ribeiro MC, Lobert H, Artes R. Maternal psychological stress and distress as predictors of low birth weight, prematurity and intrauterine growth retardation. Eur J Clin Nutri. 2003;57(2):266–72.CrossRef
12.
13.
Zimmer EZ, Divon MY. Sonographic diagnosis of IUGR-macrosomia. Clin Obstet Gynecol. 1992;35(1):172–84.PubMedCrossRef
14.
Banister CE, Koestler DC, Maccani MA, Padbury JF, Houseman EA, Marsit CJ. Infant growth restriction is associated with distinct patterns of DNA methylation in human placentas. Epigenetics. 2011;6(7):920–7.PubMedPubMedCentralCrossRef
15.
Ishida M, Moore GE. The role of imprinted genes in humans. Mol Aspect Med. 2012.
16.
Takahashi N, Okamoto A, Kobayashi R, Shirai M, Obata Y, Ogawa H, et al. Deletion of Gtl2, imprinted non-coding RNA, with its differentially methylated region induces lethal parent-origin-dependent defects in mice. Human Mol Gen. 2009;18(10):1879–88.CrossRef
17.
Liu Y, Murphy SK, Murtha AP, Fuemmeler BF, Schildkraut J, Huang Z, et al. Depression in pregnancy, infant birth weight and DNA methylation of imprint regulatory elements. Epigenetics. 2012;7(7):735–46.PubMedPubMedCentralCrossRef
18.
19.
20.
21.
22.
Deuschle M, Blum WF, Englaro P, Schweiger U, Weber B, Pflaum CD, et al. Plasma leptin in depressed patients and healthy controls. Horm Metab Res. 1996;28(12):714–7.PubMedCrossRef
23.
Antonijevic IA, Murck H, Frieboes RM, Horn R, Brabant G, Steiger A. Elevated nocturnal profiles of serum leptin in patients with depression. J Psychiat Res. 1998;32(6):403–10.PubMedCrossRef
24.
Rubin RT, Rhodes ME, Czambel RK. Sexual diergism of baseline plasma leptin and leptin suppression by arginine vasopressin in major depressives and matched controls. Psychiat Res. 2002;113(3):255–68.CrossRef
25.
Jow GM, Yang TT, Chen CL. Leptin and cholesterol levels are low in major depressive disorder, but high in schizophrenia. J Affect Disord. 2006;90(1):21–7.PubMedCrossRef
26.
Lawson EA, Miller KK, Blum JI, Meenaghan E, Misra M, Eddy KT, et al. Leptin levels are associated with decreased depressive symptoms in women across the weight spectrum, independent of body fat. Clin Endocrin. 2012;76(4):520–5.CrossRef
27.
Kraus T, Haack M, Schuld A, Hinze-Selch D, Pollmacher T. Low leptin levels but normal body mass indices in patients with depression or schizophrenia. Neuroendocrinology. 2001;73(4):243–7.PubMedCrossRef
28.
Zeman M, Jirak R, Jachymova M, Vecka M, Tvrzicka E, Zak A. Leptin, adiponectin, leptin to adiponectin ratio and insulin resistance in depressive women. Neuro Endocrinol Lett. 2009;30(3):387–95.PubMed
29.
Ren RX, Shen Y. A meta-analysis of relationship between birth weight and cord blood leptin levels in newborns. WJP. 2010;6(4):311–6.PubMed
30.
Karakosta P, Chatzi L, Plana E, Margioris A, Castanas E, Kogevinas M. Leptin levels in cord blood and anthropometric measures at birth: a systematic review and meta-analysis. Paediatr Perinat Epidemiol. 2011;25(2):150–63.PubMedCrossRef
31.
Lesseur C, Armstrong DA, Paquette AG, Koestler DC, Padbury JF, Marsit CJ. Tissue-specific Leptin promoter DNA methylation is associated with maternal and infant perinatal factors. Mol Cell Endocrinol. 2013;381(1–2):160–7.PubMedPubMedCentralCrossRef
32.
Struwe E, Berzl GM, Schild RL, Dotsch J. Gene expression of placental hormones regulating energy balance in small for gestational age neonates. Eur J Obstet Gynecol Reprod Biol. 2009;142(1):38–42.PubMedCrossRef
33.
Tzschoppe A, Struwe E, Rascher W, Dorr HG, Schild RL, Goecke TW, et al. Intrauterine growth restriction (IUGR) is associated with increased leptin synthesis and binding capability in neonates. Clin Endocrinol (Oxf). 2011;74(4):459–66.CrossRef
34.
Shroff MR, Holzman C, Tian Y, Evans RW, Sikorskii A. Mid-pregnancy maternal leptin levels, birthweight for gestational age and preterm delivery. Clin Endocrinol (Oxf). 2013;78(4):607–13.CrossRef
35.
Catov JM, Patrick TE, Powers RW, Ness RB, Harger G, Roberts JM. Maternal leptin across pregnancy in women with small-for-gestational-age infants. Am J Obstet Gynecol. 2007;196(6):558.PubMedCrossRef
36.
Franco-Sena AB, Goldani MZ, Tavares do Carmo M, Velasquez-Melendez G, Kac G. Low leptin concentration in the first gestational trimester is associated with being born small for gestational age: prospective study in Rio de Janeiro. Brazil Neonatology. 2010;97(4):291–8.PubMedCrossRef
37.
Mise H, Yura S, Itoh H, Nuamah MA, Takemura M, Sagawa N, et al. The relationship between maternal plasma leptin levels and fetal growth restriction. Endocr J. 2007;54(6):945–51.PubMedCrossRef
38.
Verhaeghe J, van Bree R, Van Herck E. Maternal body size and birth weight: can insulin or adipokines do better? Metabolism: Clin Experimen. 2006;55(3):339–44.CrossRef
39.
Pighetti M, Tommaselli GA, D'Elia A, Di Carlo C, Mariano A, Di Carlo A, et al. Maternal serum and umbilical cord blood leptin concentrations with fetal growth restriction. Obstet Gynecol. 2003;102(3):535–43.PubMed
40.
Hedley P, Pihl K, Krebs L, Larsen T, Christiansen M. Leptin in first trimester pregnancy serum: no reduction associated with small-for-gestational-age infants. Reprod Biomed Online. 2009;18(6):832–7.PubMedCrossRef
41.
Tamura T, Goldenberg RL, Johnston KE, Cliver SP. Serum leptin concentrations during pregnancy and their relationship to fetal growth. Obstet Gynecol. 1998;91(3):389–95.PubMedCrossRef
42.
Yildiz L, Avci B, Ingec M. Umbilical cord and maternal blood leptin concentrations in intrauterine growth retardation. CCLM / FESCC. 2002;40(11):1114–7.
43.
Papadopoulou FG, Mamopoulos AM, Triantos A, Constantinidis TC, Papadimas J, Assimakopoulos EA, et al. Leptin levels in maternal and cord serum: relationship with fetal development and placental weight. J Matern Fetal Med. 2000;9(5):298–302.PubMedCrossRef
44.
Maymo JL, Perez AP, Gambino Y, Calvo JC, Sanchez-Margalet V, Varone CL. Review: Leptin gene expression in the placenta--regulation of a key hormone in trophoblast proliferation and survival. Placenta. 2011;32 Suppl 2:S146–53.PubMedCrossRef
45.
Khalyfa A, Carreras A, Hakim F, Cunningham JM, Wang Y, Gozal D. Effects of late gestational high-fat diet on body weight, metabolic regulation and adipokine expression in offspring. Int J Obes. 2013;37(11):1481–9.CrossRef
46.
Bennett HA, Einarson A, Taddio A, Koren G, Einarson TR. Prevalence of depression during pregnancy: systematic review. Obstet Gynecol. 2004;103(4):698–709.PubMedCrossRef
47.
Marcus SM, Flynn HA, Blow FC, Barry KL. Depressive symptoms among pregnant women screened in obstetrics settings. J Women's Health. 2003;12(4):373–80.CrossRef
48.
Heron J, O'Connor TG, Evans J, Golding J, Glover V. The course of anxiety and depression through pregnancy and the postpartum in a community sample. J Affect Disord. 2004;80(1):65–73.PubMedCrossRef
49.
Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of in utero and early-life conditions on adult health and disease. N Engl J Med. 2008;359(1):61–73.PubMedPubMedCentralCrossRef
50.
de Bie HM, Oostrom KJ, de Waal HA D-v. Brain development, intelligence and cognitive outcome in children born small for gestational age. Horm Res Paediatr. 2010;73(1):6–14.PubMedCrossRef
51.
Pallotto EK, Kilbride HW. Perinatal outcome and later implications of intrauterine growth restriction. Clin Obstet Gynecol. 2006;49(2):257–69.PubMedCrossRef
Metadata
Title
Maternal psychiatric disease and epigenetic evidence suggest a common biology for poor fetal growth
Authors
Timothy H. Ciesielski
Carmen J. Marsit
Scott M. Williams
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Pregnancy and Childbirth / Issue 1/2015
Electronic ISSN: 1471-2393
DOI
https://doi.org/10.1186/s12884-015-0627-8

Other articles of this Issue 1/2015

BMC Pregnancy and Childbirth 1/2015 Go to the issue

Research article

Under-utilization of antenatal care services in Timor-Leste: results from Demographic and Health Survey 2009–2010

Research article

Social support among HIV-positive and HIV-negative adolescents in Umlazi, South Africa: changes in family and partner relationships during pregnancy and the postpartum period

Research article

A qualitative study exploring the determinants of maternal health service uptake in post-conflict Burundi and Northern Uganda

Research article

Determining effects of areca (betel) nut chewing in a prospective cohort of pregnant women in Madang Province, Papua New Guinea

Erratum

Erratum: A complex intervention to improve pregnancy outcome in obese women; the UPBEAT randomised controlled trial

Research article

Barriers and enablers to implementing antenatal magnesium sulphate for fetal neuroprotection guidelines: a study using the theoretical domains framework